We’re currently closed to new orders.

Agave

Agave is one of the emerging Australian industries we're interested in — spirits, fibre, and biomass end uses across Agave tequilana, A. americana, and related species. Tissue culture is well suited to clonal propagation of selected agave planting stock, true to type.

Macro view of clonal tissue culture plantlets with new shoots and roots inside a sterile glass culture vessel

Industry background. AgriFutures Australia identifies agave as an emerging industry, with commercial plantings in Queensland and trials in the Northern Territory, Western Australia, and Victoria. See AgriFutures: Agave — a compact business case.

The industry

Agave plantations in Mexico and elsewhere are supplied almost entirely from tissue-cultured planting stock. The same approach is relevant for Australian production: long crop cycles and high planting densities mean the cost of clonal, true-to-type, disease-free planting stock is readily recovered over the life of the planting.

Why tissue culture

  • High multiplication rates from limited starting material, suitable for new cultivars
  • True-to-type plants for consistent sugar content, fibre quality, and maturity timing
  • Clean material, free of systemic pathogens picked up in field nursery production
  • Year-round production independent of offset (pup) availability from field plants

Why agave interests us

Agave is a particular focus for us. We see strong potential for tissue-cultured planting stock in the emerging Australian industry, and we'd welcome conversations with commercial and research partners exploring it.

References